<p>Rabbit immune sera collected post-3<sup>rd</sup> immunization were evaluated. Serum Ab binding titers (panel A) and avidities (panel B) elicited by monomeric and dimeric fractions of TV1.C and 1086.C gp120s. Strain matched gp120 proteins were used for the binding and avidity analyses. Virus neutralization ID50 titers elicitied by monomeric (solid symbols) and dimeric (open symbols) fractions of TV1.C (panel C) and 1086.C (panel D) against a tier 1 and tier 2 HIV-1 pseudoviruses. No statistically significant differences were observed.</p
<div><p>Development of a vaccine for HIV-1 requires a detailed understanding of the neutralizing ant...
Evaluating the structure-function relationship of viral envelope (Env) evolution and the development...
Immune complex (IC) vaccines have been successfully used to increase immune responses against variou...
<p>(A) End-point binding titers of rabbits immunized with either trimeric gp140 (filled squares) or ...
<p>Competition ELISA using various mAbs and sera to block binding of biotinylated (bio) 2G12 (A, C) ...
<p>(A) Absence of blocking of neutralization by rabbit sera by the CD4 binding site scaffold RSC3. N...
<p>ELISA titers of preimmune (black) and immune (red) rabbits' sera on gp120 IIIB (continuous line) ...
<p>Rabbits received immunizations containing 30 µg of wild type R2gp140 (⧫), R2gp140-GCN4 (▪), R2gp1...
Ten to 30% of HIV-1 infected subjects develop broadly neutralizing antibodies (bNAbs) during chronic...
<p>A-B: Profiles of rabbit IgGs from the immunization with or without (poly)peptide priming are comp...
BACKGROUND: Ten to 30% of HIV-1 infected subjects develop broadly neutralizing antibodies (bNAbs) du...
VLPs were produced by transfection into 293F cells and VLPs were pelleted from the clarified superna...
Immune complex (IC) vaccines have been successfully used to increase immune responses against variou...
<p>(A) Scheme of vaccination study in rabbits, showing time-point of administration of immunogens an...
Previously we described induction of cross-reactive HIV-1 neutralizing antibody responses in rabbits...
<div><p>Development of a vaccine for HIV-1 requires a detailed understanding of the neutralizing ant...
Evaluating the structure-function relationship of viral envelope (Env) evolution and the development...
Immune complex (IC) vaccines have been successfully used to increase immune responses against variou...
<p>(A) End-point binding titers of rabbits immunized with either trimeric gp140 (filled squares) or ...
<p>Competition ELISA using various mAbs and sera to block binding of biotinylated (bio) 2G12 (A, C) ...
<p>(A) Absence of blocking of neutralization by rabbit sera by the CD4 binding site scaffold RSC3. N...
<p>ELISA titers of preimmune (black) and immune (red) rabbits' sera on gp120 IIIB (continuous line) ...
<p>Rabbits received immunizations containing 30 µg of wild type R2gp140 (⧫), R2gp140-GCN4 (▪), R2gp1...
Ten to 30% of HIV-1 infected subjects develop broadly neutralizing antibodies (bNAbs) during chronic...
<p>A-B: Profiles of rabbit IgGs from the immunization with or without (poly)peptide priming are comp...
BACKGROUND: Ten to 30% of HIV-1 infected subjects develop broadly neutralizing antibodies (bNAbs) du...
VLPs were produced by transfection into 293F cells and VLPs were pelleted from the clarified superna...
Immune complex (IC) vaccines have been successfully used to increase immune responses against variou...
<p>(A) Scheme of vaccination study in rabbits, showing time-point of administration of immunogens an...
Previously we described induction of cross-reactive HIV-1 neutralizing antibody responses in rabbits...
<div><p>Development of a vaccine for HIV-1 requires a detailed understanding of the neutralizing ant...
Evaluating the structure-function relationship of viral envelope (Env) evolution and the development...
Immune complex (IC) vaccines have been successfully used to increase immune responses against variou...